The cardiovascular needle market in North America is expected to grow from US$ 30.55 Million in 2021 to US$ 50.85 Million by 2028; it is estimated to grow at a CAGR of 7.5% from 2021 to 2028.
Cardiovascular diseases (CVDs) are the disorders of heart and blood vessels, and the category includes cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions. Tobacco consumption, unhealthy diet, and physical inactivity, which increase the risk of heart attacks and strokes, are a few of the major lifestyle factors that lead to the CVDs. Other risk factors causing these diseases include hypertension, diabetes, and increased cholesterol levels. CVDs are among the top 10 causes of death. According to the World Health Organization (WHO), cardiovascular diseases are number one cause of the death. Cardiovascular diseases (CVDs) are likely to remain the largest cause of morbidity and mortality. Fat depositions around blood vessels that prevents blood from flowing to the heart or brain is a main cause of heart attack and stroke. Bleeding vessels or blood clots in brain are a few other causes of stroke. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the US, i.e., ~50% of the US adult population, suffer from CVDs every year. Thus, the significantly rising incidence of CVDs is contributing to the high demand for diagnostic and treatment cardiovascular devices, which is driving the cardiovascular needle market growth.Cardiac surgical patients not only require vital ICU resources but are also potentially in the highest risk category of complications of COVID-19. Hence, most of the hospitals and surgical enters has considered to cancel or postponed elective surgeries including cardiovascular surgeries. Hence impact of COVID 19 is expected to be somewhat negative on cardiovascular needle market, but it is also anticipated for short term. According to the Society of Thoracic Surgeons Adult Cardiac Surgery Database and Johns Hopkins COVID-19 database, there was a 52.7% reduction in adult cardiac surgery volume and a 65.5% reduction in elective cases in United States. After the first COVID-19 surge, nationwide cardiac surgical case volumes have declined, which indicates a COVID-19-associated impact on cardiac surgery patients. However, in long run, as the vaccination schedule will establishes and transmission rate decreases, healthcare systems will return to normal and will have increased demand for cardiovascular needle, which will support the market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the cardiovascular needle market. The North America cardiovascular needle market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
North America Cardiovascular Needle Market Segmentation
By Application
- Open Heart Surgery
- Cardiac Valve Procedures
By Usage
- Single Use
- Multiple Uses
By End User
- Hospitals and Clinics
- Ambulatory Surgical Centres
- Cardiovascular Centres
By Country
- North America
- US
- Canada
- Mexico
Companies Mentioned
- Ethicon (Johnson & Johnson Services, Inc.)
- MANI, INC
- Barber of Sheffield
- FSSB surgical needles GmbH
- Medtronic
- Teleflex Incorporated
- Meril Life Sciences Pvt. Ltd.
- CP Medical
- SMB Corporation of India
North America Cardiovascular Needle Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 30.55 Million |
Market Size by 2028 | US$ 50.85 Million |
Global CAGR (2021 - 2028) | 7.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends

















